Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer

Overview of attention for article published in World Journal of Urology, August 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 6 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Grant US-RE49353-E1

United States of America

Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Grant US-11491149-B2

United States of America

Substituted thiohydantoin derivatives as androgen receptor antagonists

Grant US-10981926-B2

United States of America

ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER

Grant EP-3305285-B1

European Patent Office

Substituted thiohydantoin derivatives as androgen receptor antagonists

Grant US-10501469-B2

United States of America

Substituted thiohydantoin derivatives as androgen receptor antagonists

Grant US-10000502-B2

United States of America